62 related articles for article (PubMed ID: 10851496)
21. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
[TBL] [Abstract][Full Text] [Related]
22. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection.
Heriot AG; Marriott JB; Cookson S; Kumar D; Dalgleish AG
Br J Cancer; 2000 Mar; 82(5):1009-12. PubMed ID: 10737381
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
24. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
[TBL] [Abstract][Full Text] [Related]
25. Soluble immunological parameters and early prognosis of renal cell cancer patients.
Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
[TBL] [Abstract][Full Text] [Related]
26. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
[TBL] [Abstract][Full Text] [Related]
27. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer.
Chen X; Hu ZP; Yang XX; Huang M; Gao Y; Tang W; Chan SY; Dai X; Ye J; Ho PC; Duan W; Yang HY; Zhu YZ; Zhou SF
Int Immunopharmacol; 2006 Mar; 6(3):499-508. PubMed ID: 16428086
[TBL] [Abstract][Full Text] [Related]
29. [Cytokines and soluble cytokine receptors in the perioperative period].
Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M
Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152
[TBL] [Abstract][Full Text] [Related]
30. In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression.
Shimazaki J; Goto Y; Nishida K; Tabuchi T; Motohashi G; Ubukata H; Tabuchi T
Oncology; 2013; 84(6):356-61. PubMed ID: 23689116
[TBL] [Abstract][Full Text] [Related]
31. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
32. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
33. [The effect of interleukin-7 and interleukin-15 on the production of Th1 and Th2 cytokines by peripheral blood mononuclear cells from patients with tuberculosis].
Yang XM; Dong DQ; Li C; Yang YH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):403-6. PubMed ID: 17045026
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy ± cetuximab modulates peripheral immune responses in metastatic colorectal cancer.
Xynos ID; Karadima ML; Voutsas IF; Amptoulach S; Skopelitis E; Kosmas C; Gritzapis AD; Tsavaris N
Oncology; 2013; 84(5):273-83. PubMed ID: 23445638
[TBL] [Abstract][Full Text] [Related]
35. Significance of inflammatory cytokines in the progression of colorectal cancer.
Chung YC; Chang YF
Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response.
Lauerova L; Dusek L; Simickova M; Kocák I; Vagundová M; Zaloudík J; Kovarík J
Neoplasma; 2002; 49(3):159-66. PubMed ID: 12098001
[TBL] [Abstract][Full Text] [Related]
37. Immunological status of patients subjected to cardiac surgery: serum levels of interleukin 6 and tumor necrosis factor alpha and the ability of peripheral blood mononuclear cells to proliferate and produce these cytokines in vitro.
Właszczyk A; Adamik B; Durek G; Kübler A; Zimecki M
Arch Immunol Ther Exp (Warsz); 1996; 44(4):225-34. PubMed ID: 9017162
[TBL] [Abstract][Full Text] [Related]
38. [Immune mechanism and clinical significance of infection immunity activation for medullary hematopoietic injury of immune-related hematocytopenia syndrome].
Sun L; Wu Q; Hao H; Du Y; Ming H; Xu G; Wang G; Li M; Zhang Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1393-400. PubMed ID: 25142990
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
40. [CEA, CA-19-9 and il-8, sTNFRII and sil-2R in persons at high risk of colorectal cancer].
Grotowski M; Wojtuń S
Pol Merkur Lekarski; 2003 Apr; 14(82):327-30. PubMed ID: 12868194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
